NCT05169684 2025-06-10A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerBristol-Myers SquibbPhase 2 Terminated10 enrolled 15 charts
NCT04918810 2024-11-22GUIDEAustralian and New Zealand Urogenital and Prostate Cancer Trials GroupPhase 2 Terminated6 enrolled